Berberine ameliorates lipopolysaccharide-induced learning and memory deficit in the rat: insights into underlying molecular mechanisms.


Journal

Metabolic brain disease
ISSN: 1573-7365
Titre abrégé: Metab Brain Dis
Pays: United States
ID NLM: 8610370

Informations de publication

Date de publication:
02 2019
Historique:
received: 30 05 2018
accepted: 15 11 2018
pubmed: 21 11 2018
medline: 7 6 2019
entrez: 21 11 2018
Statut: ppublish

Résumé

Systemic lipopolysaccharide (LPS) triggers neuroinflammation with consequent development of behavioral and cognitive deficits. Neuroinflammation plays a crucial role in the pathogenesis of neurodegenerative disorders including Alzheimer's disease (AD). Berberine is an isoquinoline alkaloid in Berberis genus with antioxidant and anti-inflammatory property and protective effects in neurodegenerative disorders. In this research, beneficial effect of this alkaloid against LPS-induced cognitive decline was assessed in the adult male rats. LPS was intraperitoneally administered at a dose of 1 mg/kg to induce neuroinflammation and berberine was given via gavage at doses of 10 or 50 mg/kg, one h after LPS, for 7 days. Treatment of LPS group with berberine at a dose of 50 mg/kg (but not at a dose of 10 mg/kg) improved spatial recognition memory in Y maze, performance in novel object recognition task (NORT), and prevented learning and memory dysfunction in passive avoidance tasks. Furthermore, berberine lowered hippocampal activity of acetylcholinesterase (AChE), malondialdehyde (MDA), protein carbonyl, activity of caspase 3, and DNA fragmentation and improved antioxidant capacity through enhancing glutathione peroxidase (GPx), superoxide dismutase (SOD), catalase, and glutathione (GSH). Besides, berberine attenuated inflammation-related indices, as was evident by lower levels of nuclear factor-kappa B (NF-κB), toll-like receptor 4 (TLR4), tumor necrosis factor α (TNFα), and interleukin 6 (IL-6). Berberine also appropriately restored hippocampal 3-nitrotyrosine (3-NT), cyclooxygenase 2 (Cox 2), glial fibrillary acidic protein (GFAP), sirtuin 1, and mitogen-activated protein kinase (p38 MAPK) with no significant alteration of brain-derived neurotrophic factor (BDNF). In summary, berberine could partially ameliorate LPS-induced cognitive deficits via partial suppression of apoptotic cascade, neuroinflammation, oxido-nitrosative stress, AChE, MAPK, and restoration of sirtuin 1.

Identifiants

pubmed: 30456649
doi: 10.1007/s11011-018-0349-5
pii: 10.1007/s11011-018-0349-5
doi:

Substances chimiques

Antioxidants 0
Lipopolysaccharides 0
Neuroprotective Agents 0
Berberine 0I8Y3P32UF
Malondialdehyde 4Y8F71G49Q
Acetylcholinesterase EC 3.1.1.7

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

245-255

Références

Vitam Horm. 2017;104:153-195
pubmed: 28215294
Curr Psychiatry Rep. 2010 Feb;12(1):39-45
pubmed: 20425309
Int J Mol Med. 2014 Apr;33(4):870-8
pubmed: 24535622
Rom J Morphol Embryol. 2015;56(3):903-13
pubmed: 26662122
Eur J Pharmacol. 2017 Jan 15;795:13-21
pubmed: 27915041
Eur J Pharmacol. 2010 Aug 25;640(1-3):206-10
pubmed: 20450904
Mol Neurobiol. 2018 May;55(5):4068-4077
pubmed: 28585188
Mol Neurobiol. 2014 Apr;49(2):820-6
pubmed: 24113841
J Neuroinflammation. 2017 Sep 20;14(1):190
pubmed: 28931410
PLoS One. 2013 Oct 31;8(10):e77969
pubmed: 24205048
Int Immunopharmacol. 2011 Jan;11(1):121-7
pubmed: 21059391
Oncotarget. 2016 Aug 30;7(35):56045-56059
pubmed: 27517628
Acta Pharmacol Sin. 2005 Mar;26(3):329-33
pubmed: 15715929
CNS Neurosci Ther. 2017 Jan;23(1):33-44
pubmed: 27421686
J Neuroinflammation. 2018 Feb 09;15(1):37
pubmed: 29426327
Neurobiol Dis. 2017 Jan;97(Pt B):114-118
pubmed: 27185594
Biomed Pharmacother. 2017 Mar;87:200-208
pubmed: 28061403
Arch Biochem Biophys. 1959 May;82(1):70-7
pubmed: 13650640
Brain Behav Immun. 2015 Feb;44:159-66
pubmed: 25451612
Pharm Biol. 2013 Nov 5;:
pubmed: 24188583
Int J Mol Sci. 2013 May 08;14(5):9820-33
pubmed: 23698769
Eur J Pharmacol. 2018 May 5;826:114-122
pubmed: 29518393
Front Mol Neurosci. 2016 Mar 08;9:19
pubmed: 27013966
Mol Med. 2015 Mar 11;20:601-11
pubmed: 25299421
J Lab Clin Med. 1967 Jul;70(1):158-69
pubmed: 6066618
Medicina (B Aires). 1998;58(4):377-85
pubmed: 9816700
Anal Biochem. 1976 May 7;72:248-54
pubmed: 942051
Neurosci Lett. 2016 Feb 12;614:77-82
pubmed: 26773864
J Neuroinflammation. 2015 Jan 09;12:3
pubmed: 25573647
Methods Enzymol. 1990;186:464-78
pubmed: 1978225
Inflammation. 2016 Aug;39(4):1441-52
pubmed: 27192986
Food Chem Toxicol. 2018 Jan;111:432-444
pubmed: 29170048
Neurol Res. 2017 Jan;39(1):73-82
pubmed: 27809706
J Inflamm (Lond). 2010 Mar 30;7:16
pubmed: 20353590
Acta Med Iran. 2016 Apr;54(4):245-50
pubmed: 27309265
Exp Neurol. 2003 Dec;184(2):794-804
pubmed: 14769372
Food Chem Toxicol. 2013 Dec;62:397-406
pubmed: 24025684
Physiol Res. 2017 Sep 22;66(4):553-565
pubmed: 28406691
Metab Brain Dis. 2015 Aug;30(4):935-42
pubmed: 25600690
BMC Neurol. 2014 Jul 15;14:145
pubmed: 25027645
Mol Med Rep. 2018 May;17(5):6881-6886
pubmed: 29512719
Iran J Basic Med Sci. 2018 Jan;21(1):53-58
pubmed: 29372037
J Neuroinflammation. 2014 May 06;11:85
pubmed: 24886300
Front Neurosci. 2018 Jun 08;12:384
pubmed: 29937710
Behav Brain Res. 2012 Mar 17;228(2):423-31
pubmed: 22209851
Neurochem Res. 2018 Sep;43(9):1814-1825
pubmed: 30027364
Ecotoxicol Environ Saf. 2011 Oct;74(7):2105-11
pubmed: 21719105
Biochem Biophys Res Commun. 2002 Nov 29;299(2):201-7
pubmed: 12437970
Anal Biochem. 1968 Oct 24;25(1):192-205
pubmed: 4973948
Biochem Pharmacol. 1961 Jul;7:88-95
pubmed: 13726518
Eur J Pharmacol. 2017 Jan 5;794:69-76
pubmed: 27887948
Neuroscience. 2013 Jun 14;240:27-38
pubmed: 23485816
J Ethnopharmacol. 2018 May 10;217:98-106
pubmed: 29447949
J Neuroinflammation. 2008 May 13;5:15
pubmed: 18477398
Mol Neurobiol. 2017 Jul;54(5):3350-3367
pubmed: 27167130
Mol Psychiatry. 2018 Feb;23(2):323-334
pubmed: 28093569
Peptides. 2016 Dec;86:102-111
pubmed: 27777064
Metab Brain Dis. 2018 Jun;33(3):681-691
pubmed: 29277879
Naunyn Schmiedebergs Arch Pharmacol. 2016 Jun;389(6):637-56
pubmed: 27026404
PLoS One. 2013 Sep 10;8(9):e75467
pubmed: 24040413
Oxid Med Cell Longev. 2015;2015:610813
pubmed: 25834699
Exp Ther Med. 2018 Jan;15(1):1129-1135
pubmed: 29399112
Biochem Biophys Res Commun. 2017 Feb 5;483(2):885-891
pubmed: 28077277
Oxid Med Cell Longev. 2016;2016:1689602
pubmed: 26788242
J Nutr Biochem. 2018 Jun;56:16-25
pubmed: 29454265
Mol Neurobiol. 2018 Aug;55(8):6282-6306
pubmed: 29294244
Cogn Process. 2012 May;13(2):93-110
pubmed: 22160349
Sci China Life Sci. 2015 Jun;58(6):564-9
pubmed: 25749423
Drug Discov Ther. 2013 Dec;7(6):261-71
pubmed: 24423658
Mol Neurobiol. 2015 Aug;52(1):653-63
pubmed: 25257696
Pharmacol Biochem Behav. 2015 Sep;136:13-20
pubmed: 26159088
Pharm Biol. 2015;53(12):1803-9
pubmed: 25885938
Int Immunopharmacol. 2017 Nov;52:290-296
pubmed: 28963942
J Chem Neuroanat. 2018 Jan;87:54-59
pubmed: 28495517
Neurotoxicol Teratol. 2002 Sep-Oct;24(5):695-701
pubmed: 12200200
J Neuroinflammation. 2015 Jun 26;12:124
pubmed: 26112466
Exp Ther Med. 2014 Mar;7(3):750-754
pubmed: 24520281
Cytokine. 2018 Apr;104:151-159
pubmed: 29102164
Lancet Neurol. 2014 Jun;13(6):630-6
pubmed: 24849863

Auteurs

Sepideh Sadraie (S)

School of Medicine, Shahed University, Tehran, Iran.

Zahra Kiasalari (Z)

Neurophysiology Research Center, Shahed University, Tehran, Iran.

Mohadeseh Razavian (M)

School of Medicine, Shahed University, Tehran, Iran.

Shekoofe Azimi (S)

Department of Physiology, School of Medicine, Shahed University, Tehran, Iran.

Ladan Sedighnejad (L)

Department of Physiology, School of Medicine, Shahed University, Tehran, Iran.

Siamak Afshin-Majd (S)

Neurophysiology Research Center, Shahed University, Tehran, Iran.
Department of Neurology, School of Medicine, Shahed University, Tehran, Iran.

Tourandokht Baluchnejadmojarad (T)

Department of Physiology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.

Mehrdad Roghani (M)

Neurophysiology Research Center, Shahed University, Tehran, Iran. mehjour@yahoo.com.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH